AsmaSohailKhanMD

Adrenal Disease, Diabetes, Pituitary Disorders & Neuroendocrinology, Thyroid

Endocrinologist.

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of Missouri-ColumbiaFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
University of Tennessee College of Medicine at ChattanoogaResidency, Internal Medicine, 2004 - 2007
Rawalpindi Medical CollegeClass of 1987

PubMed

Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability.
Riazuddin, S.,Hussain, M.,Razzaq, A.,Iqbal, Z.,Shahzad, M.,Polla, D. L.,Song, Y.,van Beusekom, E.,Khan, A. A.,Tomas-Roca, L.,Rashid, M.,Zahoor, M. Y.,Wissink-Lindhout,...> ;Mol. Psychiatry. 2016 Jul 28
Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma c...
Hussain, A. R., Ahmed, M., Ahmed, S. O., Al-Thari, S., Khan, A. S., Razack, S., Platanias, L. C., Al-Kuraya, K. S., Uddin, S.> ;Leuk Lymphoma. 2009 Jul 01
Developing curcumin into a viable therapeutic for lymphoma.
Uddin, S., Khan, A. S., Al-Kuraya, K. S.> ;Expert Opin Investig Drugs. 2009 Jan 01
Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.
Hussain, A.R., Ahmed, M., Al-Jomah, N.A., Khan, A.S., Manogaran, P., Sultana, M., Abubaker, J., Platanias, L.C., Al-Kuraya, K.S., Uddin, S.> ;Mol Cancer Ther. 2008-10-01
Join now to see all